Our research program aims to discover and disentangle determinants and mechanisms of cardiovascular and metabolic disease using large-scale molecular and epidemiological methods in human population studies and functional model systems. Much of our research is translational, trying to bridge molecular biology and clinical medicine using large-scale platforms for genomics, transcriptomics, proteomics and metabolomics, as well as functional genomics using CRISPR-Cas9 in model systems.
We aspire to be a world-leading, vibrant and creative research environment with many exciting projects within large-scale genetic and biomarker projects, as well as using functional approaches. Our research is projected to lead to new important insights of disease mechanisms, which can facilitate development of new treatments of these diseases, as well as to new biomarkers of disease for improved risk prediction and prognostication.
We are always interested in recruiting new members to our team. Read more here.